Skip to content
Home/Companies/Biotech/Omthera Pharmaceuticals

Omthera Pharmaceuticals

Biotech·United States·Exited 2013·Held 3yr
Entry
2010
Hold
3yr
Exit
2013

Who owns Omthera Pharmaceuticals?

Omthera Pharmaceuticals is an American Biotech company, now owned by AstraZeneca, which acquired it in 2013 from Sofinnova Partners.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Sofinnova Partners
Investor
Sofinnova Partners
Sofinnova Capital VI · 2008 · Life Sciences VC

Key facts

HQUnited States
SectorBiotech
Exit Type
Trade Sale
Buyer
AstraZeneca
Exit Year
2013

More from Sofinnova Capital VI

Other portfolio companies in the same fund.

ABIONYX Pharma
Exited 2020
BiotechFrance· 2010
DBV
Exited 2014
BiotechFrance· 2010
Ablynx NV
Exited 2018
BiotechBelgium· 2008
to Sanofi
Addex Therapeutics
Exited 2012
BiotechSwitzerland· 2008
Movetis
Exited 2010
BiotechBelgium· 2008
to Shire
Noxxon Pharma
Exited 2016
BiotechGermany· 2008

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Omthera Pharmaceuticals?

Omthera Pharmaceuticals is now owned by AstraZeneca, which acquired it in 2013 from Sofinnova Partners.

When did AstraZeneca acquire Omthera Pharmaceuticals?

AstraZeneca acquired Omthera Pharmaceuticals in 2013, buying from Sofinnova Partners.

Who did Omthera Pharmaceuticals sell to?

Sofinnova Partners sold Omthera Pharmaceuticals to AstraZeneca in 2013 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue